Tom Frohlich

Tom Frohlich

Directeur Général chez JADE BIOSCIENCES, INC.
50 ans
Health Technology
Consumer Services
Finance

Profil

Tom Frohlich was the founder of Chinook Therapeutics, Inc., founded in 2019, where the title held was Chief Operating Officer from 2021 to 2023.
Current jobs include Chief Executive Officer & Director at Jade Biosciences, Inc. (United States) starting in 2024, and Chief Executive Officer & Director at Jade Biosciences, Inc. starting in 2025.
Former jobs include Vice President-Business Development at Arbutus Biopharma Corp.
from 2016 to 2018, Senior Vice President-Business Development at Inception Sciences, Inc. in 2018, and Entrepreneur-in-Residence at Versant Ventures Canada Ltd. Education includes an MBA from the University of Oxford in 2007 and an undergraduate degree from the University of Victoria in 1998.

Postes actifs de Tom Frohlich

SociétésPosteDébut
JADE BIOSCIENCES, INC. Directeur Général 28/04/2025

Anciens postes connus de Tom Frohlich

SociétésPosteFin
CHINOOK THERAPEUTICS, INC. Fondateur 01/10/2023
Corporate Officer/Principal 01/12/2018
ARBUTUS BIOPHARMA CORPORATION Corporate Officer/Principal 01/03/2018
Private Equity Investor -
Voir l'expérience en détail de Tom Frohlich

Formation de Tom Frohlich

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

90

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Tom Frohlich
🔇